Drugs Made In America Acquisition Corp. (DMAA)

Price & Market Data

Price: $10.60

Daily Change: $0.00 / 0.00%

Daily Range: $10.60 - $10.60

Market Cap: $357,401,728

Daily Volume: 248

Performance Metrics

1 Week: 0.19%

1 Month: 0.81%

3 Months: 1.63%

6 Months: 2.79%

1 Year: 4.85%

YTD: 2.18%

About Drugs Made In America Acquisition Corp. (DMAA)

Comprehensive review of Drugs Made In America Acquisition Corp. (DMAA). Trading at 10.60, the stock has seen a daily change of $0.00 / 0.00%. Its market capitalization is 357,401,728. All performance data is available for analysis.

Company Details

Employees: 2

Sector: Finance

Industry: Financial conglomerates

Country: United States

Details

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Selected stocks

Reading International Inc (RDIB)

Immuron Limited (IMRN)

Asia Pacific Wire & Cable Corporation Limited (APWC)

FactSet Research Systems Inc. (FDS)

Kaltura, Inc. (KLTR)